Optimized Alectinib Dose Regimen for Treatment of Patients With ALK‐Positive Non‐Small Cell Lung Cancer Based on Robust Pharmacometric Analyses and Clinical Evidence. Issue 5 (8th August 2021)

Record Type:: Journal Article
Title:: Optimized Alectinib Dose Regimen for Treatment of Patients With ALK‐Positive Non‐Small Cell Lung Cancer Based on Robust Pharmacometric Analyses and Clinical Evidence. Issue 5 (8th August 2021)
Main Title:: Optimized Alectinib Dose Regimen for Treatment of Patients With ALK‐Positive Non‐Small Cell Lung Cancer Based on Robust Pharmacometric Analyses and Clinical Evidence
Authors:: Frey, Nicolas
Bordogna, Walter
Balas, Bogdana
Ruf, Thorsten
Archer, Venice
Guerini, Elena
Abstract:
Is Part Of:: Clinical pharmacology & therapeutics. Volume 110:Issue 5(2021)
Journal:: Clinical pharmacology & therapeutics
Issue:: Volume 110:Issue 5(2021)
Issue Display:: Volume 110, Issue 5 (2021)
Year:: 2021
Volume:: 110
Issue:: 5
Issue Sort Value:: 2021-0110-0005-0000
Page Start:: 1162
Page End:: 1163
Publication Date:: 2021-08-08
Subjects:: Pharmacology -- Periodicals
Therapeutics -- Periodicals
615.5
Journal URLs:: http://www.nature.com/clpt/index.html ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1532-6535 ↗
http://www.nature.com/ ↗
http://firstsearch.oclc.org ↗
http://www.mosby.com/cpt ↗
http://www.sciencedirect.com/science/journal/00099236 ↗
http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchdbfor=home&id=cp ↗
DOI:: 10.1002/cpt.2373 ↗
Languages:: English
ISSNs:: 0009-9236
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3286.330000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 26813.xml